Category Archives: ADD ADHD

  • -

TENS PEMF therapy in the management of ADD and ADHD

The following studies represent the clinical evidence for the use of TENS PEMF therapy in the management of ADD and ADHD. Please note these studies were not done on the Rife PEMF device, but do represent outputs available on our devices.

TENS PEMF therapy in the management of ADD and ADHD

For more information on ADHD and ADD, please read our article: TENS therapy for ADHD – ADHD Alternatives to medication

Effects of transcutaneous electrical nerve stimulation (TENS) on cognition, behavior, and the rest-activity rhythm in children with ADHD Twenty-two children diagnosed with ADHD-CT received TENS treatment during 6 weeks, 2 times 30 min a day. Neuropsychological tests were administered to assess cognition, parent/teacher behavioral rating scales were used to measure behavior, and actigraphy was used to assess the rest-activity rhythm. TENS appeared to have a moderate beneficial influence on cognitive functions that load particularly on executive function. There was also improvement in behavior as measured by parent/teacher behavioral rating scales. Moreover, motor restlessness during sleep and motor activity during the day decreased by TENS. CONCLUSIONS: The effects of TENS in children with ADHD are modest but encouraging and warrant further research.
Transcranial magnetic stimulation (TMS) in the treatment of attention-deficit/hyperactivity disorder in adolescents and young adults: a pilot study In 2012, Weaver et al. performed a pilot trial of 9 adolescents and young adults, age 15-20, using 10 Hz rTMS to the right dorsolateral prefrontal cortex 97. Subjects underwent 10 sessions over two weeks and each subject was crossed-over to receive sham. The objective of the study was to assess safety and the conclusion was that this was that rTMS was safe in this cohort, but the study was underpowered to show efficacy. Although the authors reported an improvement in core ADHD symptoms in the treatment group the effect did not differ significantly from the sham condition. 10Hz
Positive effects of repetitive transcranial magnetic stimulation on attention in ADHD Subjects: a randomized controlled pilot study. In 2010, Bloch et al. performed a double blind, randomized, sham controlled crossover pilot study with positive effects in 13 patients
Effectiveness of the repetitive Transcranical Magnetic Stimulation (rTMS) of 1 Hz for Attention-Deficit Hyperactivity Disorder (ADHD). The purpose of our study is to verify the therapeutic effectiveness of repetitive Transcranial Magnetic Stimulation (low frequency (1Hz, 1200 stim/die for five days)), applied on the impending scalp additional motor area, in a subject affected by ADHD. Results show a significant improvement that lasted for at least 4 weeks. Placebo control did not show any improvement. 1Hz
Saftey of TMS TMS has been used in over 800 normal children and over 300 neurologically abnormal children, with a good tolerability and safety profile 105,106. No change in auditory function has been reported in the pediatric population to date 105. Single- or paired-pulse TMS has not been shown to cause seizures in children, including those with epilepsy or with conditions like cerebral palsy that are associated with increased risk of seizures 101,107-113. One case of rTMS-induced seizure was reported in an adolescent patient being treated for depression 114, though other risk factors for seizure were also present, including alcohol use the night before the induced seizure 95. In 2009, a consensus conference issued recommendations for the safe use TMS in the pediatric population. They concluded that single-pulse and paired-pulse TMS was safe for children two years and older. In the absence of an appreciable volume of data on the potential for adverse effects with rTMS, they recommended that children should not be used as subjects for rTMS without compelling clinical reasons, such as the treatment of particular psychiatric conditions
Noninvasive Brain Stimulation in Pediatric ADHD: A Review An ongoing study is investigating the use of tDCS in adult patients with ADHD, which uses anodal tDCS stimulation over the left dorsolateral preftonal cortex at 1 mA127. The aim of this parallel, randomized, double-blind, sham-controlled trial is to study the modulation of inhibitory control in this population. While the results of tDCS in ADHD are not yet available there is a burgeoning literature suggesting that tDCS may be used to improve cognitive performance. These studies have shown that tDCS can improve behavioural inhibition, memory, and attention in healthy subjects 128,129, and these findings extend to clinical populations 127,130. There is reason to be optimistic that similar stimulation paradigms may have a beneficial effect for ADHD patients, though it will be critical that future studies be sufficiently powered and include a sham-controlled experimental design.
Transcranial direct current stimulation improves clinical symptoms in adolescents with attention deficit hyperactivity disorder Anodal transcranial direct current stimulation (tDCS) of the prefrontal cortex has repeatedly been shown to improve working memory. As patients with attention deficit hyperactivity disorder (ADHD) are characterized by both underactivation of the prefrontal cortex and deficits in working memory that correlate with clinical symptoms, it is hypothesized that the modulation of prefrontal activity with tDCS in patients with ADHD increases performance in working memory and reduces symptoms of ADHD. To test this hypothesis, fifteen adolescents with ADHD (12-16 years old, three girls and 12 boys) were treated according to the randomized, double-blinded, sham-controlled, crossover design with either 1 mA anodal tDCS over the left dorsolateral prefrontal cortex or with the sham protocol 5 days each with a 2 weeks pause between these conditions. Anodal tDCS caused a significant reduction in clinical symptoms of inattention and impulsivity in adolescents with ADHD compared to sham stimulation. The clinical effects were supported by a significant reduction in inattention and hyperactivity in a standardized working memory test (QbTest). The described effects were more pronounced 7 days after the end of stimulation, a fact which emphasizes the long-lasting clinical and neuropsychological changes after tDCS. This study provides the first evidence that tDCS may reduce symptoms of ADHD and improve neuropsychological functioning in adolescents and points on the potential of tDCS as a form of treatment for ADHD. 1 mA
Positive effects of transcranial direct current stimulation in adult patients with attention-deficit/hyperactivity disorder - A pilot randomized controlled study. We performed a double-blind, sham-controlled randomized clinical trial in 17 patients with ADHD. The set up for tDCS was the following: 2mA/20min/day for 5 days with the anode over the right dorsolateral prefrontal cortex and cathode over the left dorsolateral prefrontal cortex. ADHD symptoms were measured by the Adult ADHD Self-Report Scale (ASRS) and impairment with the Sheehan Disability Scale (SDS) in four different time points after stimulation. Participants achieved significant lower ASRS inattention and SDS scores after active tDCS in comparison with sham stimulation group. In addition, we detected a trend for a lower ASRS total score in the active tDCS group. Follow up data analysis revealed a positive interaction between time and treatment in both ASRS inattention, SDS and ASRS total scores. Short-term application of tDCS in adult patients with ADHD improved their symptoms, and this improvement persisted after the end of the stimulation. Future studies with larger sample sizes are needed. 2mA/20min/day

To keep up to date on the latest studies, and clinical evidence for TENS PEMF therapy in the management of ADD and ADHD, please feel free to join our newsletter, or check back periodically.


  • -

TENS therapy for ADHD – ADHD Alternatives to medication

For most of us, sitting still and concentrating on something we want to do, or need to, is a fairly simple task but for those struggling with ADHD, simple tasks can be near impossible. Although there are several medications which can be beneficial for patients with ADHD, more and more people are searching for ADHD alternatives to medication. TENS therapy for ADHD may be the alternative they are looking for. In fact, often TENS and other electrotherapies can be used along with other therapies.

TENS therapy for ADHD

Symptoms of ADHD include an inability to pay attention, making careless mistakes, not being able to listen efficiently, inability to follow through on instructions, difficulty organizing, being easily distracted, forgetful and constant fidgeting or an inability to remain seated or calm. For parents of ADHD children, these symptoms can severely impact on home and school life and for adults, these symptoms can interfere with the ability to be efficient at work and may even prevent a person from securing a job.

Therapies that can help to reduce the symptoms by improving concentration, memory and other cognitive functions, can therefore change lives.

TENS therapy, rTMS, and TDCs all use micro-current electricity to stimulate the brain to support, improve and address various cognitive functions. There are some promising research papers dealing with rTMS, tDCS and TENS therapy for ADHD and we hope to share some of those studies with you here.

Studies on rTMS, tDCS and TENS Therapy for ADHD

In the first study, researchers studied the effects of TENS therapy on 22 children who had been diagnosed with ADHD of the combined type. The children were given treatments for 6 weeks, twice a day for 30 minutes per session. The results of the study concluded that TENS therapy for ADHD in this was encouraging and further studies were recommended. The study showed that tens seemed to have a moderate beneficial influence on the cognitive functions of the children involved in the study.

In 2012, researchers studied the effects of TMS or transcranial stimulation on the treatment of ADHD. The study consisted of 9 young adults between the ages of 15 and 20. This study used 10Hz and included a sham group as part of the study. The study concluded that rTMS was safe for use in adolescents and the researchers reports an improvement in core ADHD symptoms in the active group.

In 2010, a study was conducted to asses the positive effects of rTMS on subjects with ADHD and they found that rTMS had positive effects in 13 patients involved in the study.

1Hz stimulation has also been studied in rTMS and TENS therapy for ADHD. Researchers applied 1Hz on the motor area of the scalp in patients affected with ADHD and they found significant improvement in the patients and they also reported that the improvements lasted for 4 weeks. There was no improvement in the sham group in this trial.

TDCS therapy has also been shown to improve symptoms in young adults with ADHD. 15 children aged 12 to 16, diagnosed with ADHD, were included in a random sham-controlled study where 1mA anodal TDCS was administered for 5 days each followed by a two week pause in therapy. The therapy showed a significant reduction in the symptoms of impulsivity and inattention. The results were supported by a decrease in hyperactivity and inattention in the QbTest – the standardized working memory test. The study concluded that the results provide evidence that tDCS may help to reduce the symptoms of ADHD and they offer proof of improved neuropsychological functioning in young ADHD patients.

Finally, in a sham-controlled, randomized clinical trial, researchers evaluated the effects of 2mA tDCS therapy on 17 patients who had been diagnosed with ADHD. The patients received 5 days of therapy with the anode over the right prefrontal cortex. They measured ADHD symptoms using the ADHD Self report scale and they also measured impairment using the SDS scale. They found that therapy resulted in significantly lower ASRS and SDS scores when compared to the sham group. They also observed that the improved symptoms continued after the treatment.

Safety of tTMS, TDCS and TENS therapy for ADHD

In the review of non-invasive brain stimulation for ADHD, researchers made a number of remarks regarding the safety of TENS therapy for ADHD. According to the revierw, over 800 normal and 300 neurologically abnormal children had received therapy with good tolerability and safety.

Studies showed there had been no changes in auditory function, the therapy did not cause seizures in children including those with epilepsy. There was no increased risk in seizures in children with cerebral palsy. According to their research, one case of seizure in rTMS therapy was reported in the treatment of depression although that case had other risk factors present which increased seizure risk.

In 2009, a consensus conference issued recommendations for the safe use TMS in the pediatric population that single-pulse and paired-pulse TMS was safe for children two years and older.

Obviously, if you are investigating the benefits of TENS therapy for ADHD and you are considering investing in a model MA200 device, then we suggest you work with a medical practitioner both for diagnostic and prognosis of the condition.

Conclusions on TENS therapy for ADHD

Most of the studies on TENS therapy for ADHD have concluded that TENS and other therapies like tDCS and rTMS hold potential benefits for ADHD patients. The interesting thing to note is that most of these therapies, like TENS and tDCS are also often compatible with many of the medications used so these therapies can often be used in conjunction with other medication and therapies to address the symptoms of ADHD.

This means that, working with your practitioner, you can add TENS therapy to your choice of therapies without having to discontinue other therapies or medications. Since TENS therapies may be advantageous for other things like improving memory, and even improving sleep, TENS therapy may offer a comprehensive approach which can be included in ADHD therapy making TENS therapy of ADHD a viable addition to various treatment protocols.


Cart